NEW BIOTECHNOLOGICAL APPROACH TO REDUCE THE INCREASE OF THE PROTEASE CONCENTRATION DURING EXTRACORPOREAL BLOOD CIRCULATION IN HEMODIALYSIS OR CARDIOPULMONARY BYPASS OPERATIONS